|
Volumn 54, Issue 4, 2002, Pages 453-456
|
Introduction and overview of peptide and protein pegylation
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALBUMIN;
ANTIBODY;
ASPARAGINASE MACROGOL;
CYTOKINE;
DEXTRAN DERIVATIVE;
DEXTRAN STREPTOKINASE;
GROWTH HORMONE RELEASING FACTOR;
HORMONE;
LIPOSOME;
MACROGOL DERIVATIVE;
MACROGOL PROTEIN CONJUGATE;
PEG 'INTRON';
PEGADEMASE;
PEGINTERFERON ALPHA2A;
PEGINTERFERON ALPHA2B;
POLYETHYLENE GLYCOL ANTIBODY CONJUGATE;
POLYETHYLENE GLYCOL GRANULOCYTE COLONY STIMULATING FACTOR;
POLYETHYLENE GLYCOL GROWTH HORMONE ANTAGONIST;
POLYMER;
POLYSACCHARIDE;
STAPHYLOKINASE;
SUPEROXIDE DISMUTASE;
TUMOR NECROSIS FACTOR;
UNCLASSIFIED DRUG;
ANTIBODY PRODUCTION;
ANTIGENICITY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COVALENT BOND;
DRUG APPROVAL;
DRUG CLEARANCE;
DRUG CONJUGATION;
DRUG COST;
DRUG DEGRADATION;
DRUG DELIVERY SYSTEM;
DRUG DESIGN;
DRUG ELIMINATION;
DRUG EXCRETION;
DRUG FORMULATION;
DRUG HALF LIFE;
DRUG MARKETING;
DRUG SOLUBILITY;
DRUG STABILITY;
EDITORIAL;
EXTRACTION;
FIBRINOLYTIC THERAPY;
GENETIC ENGINEERING;
HEPATITIS C;
HUMAN;
IMMUNITY;
IMMUNOGENICITY;
NONHUMAN;
PEPTIDE SYNTHESIS;
PRIORITY JOURNAL;
PROTEIN FUNCTION;
PROTEIN IMMOBILIZATION;
PROTEIN MODIFICATION;
PROTEIN PEGYLATION;
PROTEIN PURIFICATION;
PROTEIN STRUCTURE;
URINARY EXCRETION;
DRUG CARRIERS;
PEPTIDES;
POLYETHYLENE GLYCOLS;
PROTEIN ENGINEERING;
PROTEINS;
|
EID: 0037124473
PISSN: 0169409X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0169-409X(02)00020-0 Document Type: Editorial |
Times cited : (251)
|
References (13)
|